chr3-38551477-C-A
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000335.5(SCN5A):c.4892G>T(p.Arg1631Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1631C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.4895G>T | p.Arg1632Leu | missense_variant | Exon 28 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.4892G>T | p.Arg1631Leu | missense_variant | Exon 28 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.4895G>T | p.Arg1632Leu | missense_variant | Exon 28 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.4892G>T | p.Arg1631Leu | missense_variant | Exon 28 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461798Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 727188
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
The p.R1632L variant (also known as c.4895G>T), located in coding exon 27 of the SCN5A gene, results from a G to T substitution at nucleotide position 4895. The arginine at codon 1632 is replaced by leucine, an amino acid with dissimilar properties, and is located in the DIV-S4 transmembrane region. This variant has been detected in a cohort of individuals with SCN5A variants; however, clinical detail was limited (Baruteau AE et al. Eur. Heart J., 2018 08;39:2879-2887). This variant was also detected in an asymptomatic individual with type 1 Brugada syndrome pattern on ECG (Batchvarov VN et al. J Electrocardiol, 2011;44:308). A deep mutational scanning study categorized this alteration as a possible loss of function alteration (Glazer AM et al. Circ Genom Precis Med, 2020 02;13:e002786). Internal structural analysis indicates that the arginine impacted by this alteration is part of a highly conserved set of residues that generate a characteristic motif necessary to the function of voltage-sensing channels (Gandhi CS et al. J. Gen. Physiol., 2002 Oct;120:455-63; Starace DM et al. Nature, 2004 Feb;427:548-53). Other variants affecting this codon (p.R1632H, c.4895G>A and p.R1632C, c.4894C>T) have also been reported in association with arrhythmias, including Brugada syndrome (Benson DW et al. J. Clin. Invest. 2003;112:1019-28, Nakajima T et al. Heart Rhythm. 2015 Nov;12(11):2296-304; Van Malderen SCH et al. Circ. J. 2017;82:53-61). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.